| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/12/2008 | US20080139503 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; drug delivery |
| 06/12/2008 | US20080139498 Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof |
| 06/12/2008 | US20080139497 Use of ATP in controlled regional reperfusion as treatment during acute myocardial infarction |
| 06/12/2008 | US20080139489 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis |
| 06/12/2008 | US20080139486 Red wine distillates |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139467 Method and Products For the Selective Degradation of Proteins |
| 06/12/2008 | US20080139462 Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/12/2008 | US20080138448 Composition for improving blood flow in working muscles |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138346 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/12/2008 | US20080138330 Methods and Compositions for Treating Conditions Involving Abnormal Angiogenesis |
| 06/12/2008 | US20080138321 Method for enhancing stem cell trafficking |
| 06/12/2008 | US20080138314 Use of il-22 for the treatment of conditions of metabolic disorders |
| 06/12/2008 | US20080138288 Combinations for treatment of neovasculature |
| 06/12/2008 | CA2708004A1 Conjoint therapy for treating fibrotic diseases |
| 06/12/2008 | CA2672120A1 Antagonistic antibodies against ephb3 |
| 06/12/2008 | CA2671861A1 Urea and sulfamide derivatives as tafia inhibitors |
| 06/12/2008 | CA2670674A1 Spiro-piperidine derivatives as via receptor antagonists |
| 06/12/2008 | CA2670671A1 Spiro-piperidine derivatives |
| 06/12/2008 | CA2670491A1 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930017A1 Composition effective for prevention and treatment of adult disease |
| 06/11/2008 | EP1930014A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930013A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930007A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1929998A2 Controlled release solid dispersions of carvedilol |
| 06/11/2008 | EP1929313A2 Methods to identify therapeutic agents |
| 06/11/2008 | EP1928993A1 Proanthocyanidin tannin composition, production method thereof and use of same |
| 06/11/2008 | EP1928913A2 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 06/11/2008 | EP1928842A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 06/11/2008 | EP1928836A1 Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them |
| 06/11/2008 | EP1928464A2 Novel parenteral carbamazepine formulation |
| 06/11/2008 | EP1928463A2 Method of using potassium channel inhibiting compounds |
| 06/11/2008 | EP1928454A2 Pyridone derivatives for modulating stress-activated protein kinase system |
| 06/11/2008 | EP1603908B1 Quinazoline derivatives as tgf-beta inhibitors |
| 06/11/2008 | EP1565463B1 Imidazo[1,5a] pyridine derivatives and methods for treating aldosterone mediated diseases |
| 06/11/2008 | EP1492803B1 New analogs of nitrobenzylthioinosine |
| 06/11/2008 | EP1490066B1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/11/2008 | EP1444235B1 Reverse-turn mimetics and method relating thereto |
| 06/11/2008 | EP1443816B1 Methods of treating disorders related to apoe |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1392846B1 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 06/11/2008 | EP1392334B1 Therapeutic methods using herbal compositions |
| 06/11/2008 | EP1282436B1 Treatment of acute coronary syndrome with glp-1 |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | CN101198614A Thienopyrimidine derivative |
| 06/11/2008 | CN101198609A Aspartyl protease inhibitors |
| 06/11/2008 | CN101198605A N-(pyridin-2-yl)-sulfonamide derivatives |
| 06/11/2008 | CN101198597A Preparation and use of compounds as aspartyl protease inhibitors |
| 06/11/2008 | CN101198338A Anti-hypercholesterolemic compounds |
| 06/11/2008 | CN101198316A Nanoparticulate bisphosphonate compositions |
| 06/11/2008 | CN101195647A Hydroxyl carthamus tinctorius yellow colour A, preparation method and application thereof |
| 06/11/2008 | CN101195615A Salt of imidazole-carboxylic acid derivant, production method and pharmaceutical composition thereof |
| 06/11/2008 | CN101195613A Compound with substituted tetratomic ring structure and medicine use thereof |
| 06/11/2008 | CN101195612A Compound with substituted cyclobutane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195603A Novel crystal system of pitavastatin calcium and method for producing the same |
| 06/11/2008 | CN101195586A Compound with substituted cyclopentane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195585A Compound with substituted cyclohexane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195584A Compound with substituted cyclopropane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195582A Cinnamic amide derivant |
| 06/11/2008 | CN101195031A Gluconic acid modified chitosan nucleophilic NO donator and synthesizing method thereof |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN101195019A Medicament for treating wet common cold in summer, technique of preparing its preparation and quality control method |
| 06/11/2008 | CN101195016A Medicament for treating apoplexy and technique of preparing the same |
| 06/11/2008 | CN101195012A Cordyceps sinensis medicine liqueur and preparing method |
| 06/11/2008 | CN101195003A Proprietary Chinese medicine for treating apoplexy and sequela |
| 06/11/2008 | CN101195001A Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia |
| 06/11/2008 | CN101195000A Mailuoning dropping pills and method for preparing the same |
| 06/11/2008 | CN101194999A Nano-emulsion for treating angitis and method for preparing the same |
| 06/11/2008 | CN101194996A Chinese medicine ejection preparation and method for preparing the same |
| 06/11/2008 | CN101194970A Chinese medicine for treating angitis |
| 06/11/2008 | CN101194957A Fumigation medicament for treating hemorrhoid |
| 06/11/2008 | CN101194947A Chinese medicine for treating angiocardiopathy |
| 06/11/2008 | CN101194939A Chinese medicine prescription for treating early apoplexy and hemiplegia |
| 06/11/2008 | CN101194934A Method for abstracting active compound rich in echinacoside and feltwort glycoside |
| 06/11/2008 | CN101194924A Use of lespedeza virgata in preparing medicament for activating blood circulation and removing stasis |
| 06/11/2008 | CN101194922A Acesodyne medicament dropping pills and method for preparing the same |
| 06/11/2008 | CN101194918A Technique for removing ginkgolic acid in folium ginkgo extract |
| 06/11/2008 | CN101194912A Use of ATP in controlled regional reperfusion as treatment during acute myocardial infarction |
| 06/11/2008 | CN101194904A Dropping pills containing perhexiline maleic acid and method for preparing the same |
| 06/11/2008 | CN101194893A Dropping pills containing lovastatin and method for preparing the same |
| 06/11/2008 | CN101194794A Medicine pillow for foot health care |
| 06/11/2008 | CN101194722A Foods for preventing atherosis and production method thereof |
| 06/11/2008 | CN101194705A Gourmet powder with health care function |
| 06/11/2008 | CN100393731C Water soluble phosphate ester salt ofú¿Zú®-3'-hydroxy-3,4',5-trimethoxydiphenyl ethylene, and its preparation method ,pharmaceutical composition and uses |
| 06/11/2008 | CN100393716C Coumarin derivatives, and their preparing method and use as alpha, receptor agonist |
| 06/11/2008 | CN100393715C Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 06/11/2008 | CN100393704C Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug |
| 06/11/2008 | CN100393330C Method for preparing red sage formulation or buccal tablet for treating coronary disease |
| 06/11/2008 | CN100393323C Methods of treating vascular disease |
| 06/11/2008 | CN100393319C Astragaloside cyclodextrin clathrate, its preparation and preparing mehtod |
| 06/11/2008 | CN100393315C Novel nimodipine composition |
| 06/10/2008 | US7385083 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity |